ClinicalTrials.Veeva

Menu

Autonomic Function in COPD and Risk for Atrial Fibrillation

H

Heinrich-Heine University, Duesseldorf

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Other: Measurement of lung function, electrocardiography, echocardiography and autonomic function

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In the presented study, autonomic function as well as risk for atrial fibrillation will be assessed to characterize the relation between risk of atrial fibrillation and autonomic function.

Full description

Atrial fibrillation (AF) has been suggested as relevant comorbidity in patients with chronic obstructive pulmonary disease (COPD). The evaluation of the total atrial conduction time via tissue Doppler imaging (PA-TDI interval) can be used to identify patients with increased risk of new onset AF. Autonomic function can be assessed by different non invasive clinical investigations.

The investigators hypothesise that PA-TDI interval is increased in acutely exacerbated COPD (AECOPD) compared within stable COPD and that increased PA-TDI is related to impairment of autonomic function. For this purpose, 25 patients with AECOPD and 25 patients with stable COPD were characterized by clinical characteristics, laboratory tests, lung function, electrocardiography, echocardiography and autonomic function.

Enrollment

50 patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with chronic obstructive pulmonary disease, exacerbated or stable between the age of 40-80 years with sinus rhythm who gave informed written consent

Exclusion criteria

  • Inability to give written consent, acute myocardial infarction with ST-segment elevations in last 30 days, severe acute or chronic renal dysfunction, severe heart failure, atrial fibrillation, severe valve disease, severe hypotension, active malignant disease, active rheumatic disease

Trial design

50 participants in 2 patient groups

AECOPD
Description:
acute exacerbation of COPD
Treatment:
Other: Measurement of lung function, electrocardiography, echocardiography and autonomic function
stable COPD
Treatment:
Other: Measurement of lung function, electrocardiography, echocardiography and autonomic function

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems